title: Primary intracranial plasma cell granuloma responsive to rituximab.
authors.affiliation: From the University Hospital of Cologne (C.S., T.D.H., G.R.F., M.S., H.C.L.); and the Institute of Neuroscience and Medicine (INM-3) (G.R.F.), Research Center Jülich, Germany.
authors.forename: Christian
authors.initials: C
authors.lastname: Schneider
authors.affiliation: From the University Hospital of Cologne (C.S., T.D.H., G.R.F., M.S., H.C.L.); and the Institute of Neuroscience and Medicine (INM-3) (G.R.F.), Research Center Jülich, Germany.
authors.forename: Tobias D
authors.initials: TD
authors.lastname: Henning
authors.affiliation: From the University Hospital of Cologne (C.S., T.D.H., G.R.F., M.S., H.C.L.); and the Institute of Neuroscience and Medicine (INM-3) (G.R.F.), Research Center Jülich, Germany.
authors.forename: Gereon R
authors.initials: GR
authors.lastname: Fink
authors.affiliation: From the University Hospital of Cologne (C.S., T.D.H., G.R.F., M.S., H.C.L.); and the Institute of Neuroscience and Medicine (INM-3) (G.R.F.), Research Center Jülich, Germany.
authors.forename: Michael
authors.initials: M
authors.lastname: Schroeter
authors.affiliation: From the University Hospital of Cologne (C.S., T.D.H., G.R.F., M.S., H.C.L.); and the Institute of Neuroscience and Medicine (INM-3) (G.R.F.), Research Center Jülich, Germany. helmar.lehmann@uk-koeln.de.
authors.forename: Helmar C
authors.initials: HC
authors.lastname: Lehmann
mesh_terms: D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D001921:Brain / Q000473:pathology; D001927:Brain Diseases / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D006104:Granuloma, Plasma Cell / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab